LDL cholesterol estimation in patients with the metabolic syndrome. - Test2 - elhamkhani - TriplyDB

LDL cholesterol estimation in patients with the metabolic syndrome.

LDL cholesterol estimation in patients with the metabolic syndrome.

http://www.wikidata.org/entity/Q34997089

about

Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?A modified formula for calculating low-density lipoprotein cholesterol values.Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography.Consumption of red or processed meat does not predict risk factors for coronary heart disease; results from a cohort of British adults in 1989 and 1999.Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance.Validation of the friedewald formula in patients with metabolic syndrome.Correlation of Friedewald's calculated low-density lipoprotein cholesterol levels with direct low-density lipoprotein cholesterol levels in a tertiary care hospital.Pharmacological management of diabetic dyslipidemia.Low-density lipoprotein cholesterol estimation by the Anandaraja's formula--confirmation Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes.Mediterranean Diet and 10-year (2002-2012) Incidence of Diabetes and Cardiovascular Disease in Participants with Prediabetes: The ATTICA study.

P2860

Q33776187-026EDADC-F425-4A37-A535-A2B22E748875 Q33933946-AB42B070-F25E-4D21-9155-67700E6153D9 Q37317898-88955067-7B63-4678-9B47-C41BB96EEBCB Q37398541-59CB07B8-BC0C-440E-A4C8-E7FF327CEBB9 Q37409147-5DE8BAC1-167C-47B9-83CB-58BF7F9A6CDE Q37615126-8C9C8D7F-869F-4905-8D60-2D45365EC126 Q37668464-4FE4014D-4DD6-4920-AC62-E04BC155BB12 Q39015072-5091C97C-D475-456C-88C7-6F8FD9615D51 Q41825916-D85D9F0E-20CE-40DD-B870-A815A59C4145 Q44739256-6A6691B9-57A0-4449-8D0A-25F4AF485552 Q49195408-E94DE167-B4E0-4245-AB3B-F823512C3B9B

P2860

LDL cholesterol estimation in patients with the metabolic syndrome.

http://www.wikidata.org/entity/Q34997089

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

LDL cholesterol estimation in patients with the metabolic syndrome.

@ast

LDL cholesterol estimation in patients with the metabolic syndrome.

@en

LDL cholesterol estimation in patients with the metabolic syndrome.

@nl

type

label

LDL cholesterol estimation in patients with the metabolic syndrome.

@ast

LDL cholesterol estimation in patients with the metabolic syndrome.

@en

LDL cholesterol estimation in patients with the metabolic syndrome.

@nl

prefLabel

LDL cholesterol estimation in patients with the metabolic syndrome.

@ast

LDL cholesterol estimation in patients with the metabolic syndrome.

@en

LDL cholesterol estimation in patients with the metabolic syndrome.

@nl

P1433

Q34997089-23F54073-04BD-48A3-A404-FBB752EC8E1F

P1476

Q34997089-56F8AEBC-C638-44BE-B7F3-BB61925BE139

P2093

Q34997089-0756087C-F192-4A8D-BF62-D6591136BF25

Q34997089-2B360C06-4C45-4CD1-9AEF-57C38C44ECA6

Q34997089-4C25256A-8596-4C2A-BD23-63CCED298966

Q34997089-90F31ADF-EEE3-4EFD-A74A-F2E1C288DDD2

Q34997089-CD26A1EA-CB7B-4F4F-BE06-049F78AE26B2

Q34997089-DCA59153-EF2D-47A4-A64C-5E73FB1DB222

Q34997089-E2B0F1F4-34E0-400B-905C-7376449D2C1E

P2860

Q34997089-08AE9145-1266-46BC-9177-F3BC44832E24

Q34997089-0A4A43C6-4EEF-4AC9-9E44-9DC841DADE65

Q34997089-0DC02A66-B0C5-4C76-82F4-50EDB9C26497

Q34997089-1D5D69F2-620D-4DA2-8F88-469D70F51E67

Q34997089-1F95D168-25C3-464F-8BE6-2DBDCB8C2213

Q34997089-23CB576E-1D86-4332-A960-E1E0C8C8798C

Q34997089-2A992CBD-AEE5-4D10-8610-E7826C3100F7

Q34997089-2BC69DF1-1C14-4EB1-93B6-93873783BDA9

Q34997089-39AC8819-0D5D-4EF7-BB8A-ABC26D047A9E

Q34997089-4B665C6A-683E-4AF9-AB47-250FC5F4CC7E

P2888

Q34997089-EE59EBD3-5EB7-439F-9BDD-9A29E6F02B61

P304

Q34997089-4CB00F25-0D2F-4CD8-84BE-0E2C6E042A76

P31

Q34997089-E075530B-7F90-4A12-9F36-671F60FE056D

P356

Q34997089-E60DA803-96C5-47DC-A1AD-EC366A9AE9FC

P478

Q34997089-096D7E60-5C43-4B85-88C5-E27BDBB309D5

P577

Q34997089-6B28EAFD-9C1D-4AEF-A901-19B50B379E40

P5875

Q34997089-BFDF4A68-76F3-407E-B222-645295DF9635

P6179

Q34997089-BB486E87-D1DD-4B44-ADFC-767A4D18F22E

P698

Q34997089-4DFD1731-FC37-4257-9C29-FBF8E711098B

P921

Q34997089-34F38EFB-0FCE-48A4-BA4C-486B6FA6A907

P932

Q34997089-A8C818FF-A398-47F5-AFD6-5CABCF1876FB

P356

P1433

Lipids in Health and Disease

P1476

LDL cholesterol estimation in patients with the metabolic syndrome.

@en

P2093

Alexandros D Tselepis

http://www.w3.org/2001/XMLSchema#string

Eleni T Bairaktari

http://www.w3.org/2001/XMLSchema#string

Irene Gazi

http://www.w3.org/2001/XMLSchema#string

Moses Elisaf

http://www.w3.org/2001/XMLSchema#string

Theodosios D Filippatos

http://www.w3.org/2001/XMLSchema#string

Vasilios G Saougos

http://www.w3.org/2001/XMLSchema#string

Vasilis Tsimihodimos

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System.

Dyslipidemia of central obesity and insulin resistance.

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula.

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

P2888

P304

8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-511X-5-8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7179793

http://www.w3.org/2001/XMLSchema#string

P6179

1018324923

http://www.w3.org/2001/XMLSchema#string

P698

16600020

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

1550231

http://www.w3.org/2001/XMLSchema#string